NURZIFRA
"NURZIFRA" is a word mark owned by Rosemont Pharmaceuticals Limited, filed at the USPTO on September 27, 2023. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since January 14, 2025
- Filed
- September 27, 2023
- Registered
- January 14, 2025
- Priority date
- July 7, 2023
- Claimed from United Kingdom
- Application no.
- 98200158
- Registration no.
- 7648322
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns NURZIFRA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Rosemont Pharmaceuticals Limited
Leeds, United Kingdom
Representative
Mark C. Reichel
Reichel Stohry Dean LLP
What the mark covers
The products and services NURZIFRA is filed for, grouped by Nice class.
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Assigned to lie
- Teas response to office action received
6 earlier steps on the official record.
About NURZIFRA
Who owns the trademark "NURZIFRA"?
The USPTO trademark "NURZIFRA" (application 98200158) is owned by Rosemont Pharmaceuticals Limited.
What is the status of "NURZIFRA"?
Its status at the USPTO is: registered.
When was "NURZIFRA" registered?
It was registered on January 14, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull NURZIFRA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2c23-b9c4-71cb-ba5b-8b2cae56d1d8
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2c23-b9c4-71cb-ba5b-8b2cae56d1d8",
"object": "trademark",
"mark_text": "NURZIFRA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98200158",
"filing_date": "2023-09-27",
"nice_classes": [
5
],
"owners": [
{
"name": "Rosemont Pharmaceuticals Limited",
"entity_id": "ent_019f2859-70b3-752c-a237-a47f3dc51ebe"
}
]
}